| |
BASELINE CD4 (cells/mm3)
|
DELTA CD4 after 12 months
| |
|---|
| |
Mean
|
Median
|
Interval
| |
Mean
|
Median
|
Interval
| | |
|---|
|
Non-treated (N = 10)
|
402
|
427
|
193
|
660
|
-16
|
-21
|
-112
|
64
| |
|
ARV therapies (n = 22)
|
263
|
226
|
10
|
737
|
64
|
50
|
-62
|
323
| |
|
- with PIs (n = 15)
|
230
|
237
|
10
|
527
|
106
|
89
|
-31
|
323
|
p = 0,0003
|
|
- without PIs (n = 7)
|
333
|
195
|
150
|
737
|
-25
|
-53
|
-62
|
57
| |
|
- undetectable VL (n = 8)
|
248
|
195
|
40
|
630
|
137
|
141
|
12
|
323
|
p < 0,0001
|
|
- detectable VL (n = 14)
|
272
|
226
|
10
|
737
|
23
|
16
|
-62
|
180
| |
- Interval columns give minimum and maximum CD4 cells/mm3. N is the number of patients for the untreated group, and n is the number of therapies in the treated group. p values were obtained by the analysis of variances using a Tukey test (see Methods section). PI = protease inhibitor, VL = plasma viral load.
